Literature DB >> 19167972

Lymph node dissection in the lateral neck for completion in central node-positive papillary thyroid cancer.

Andreas Machens1, Steffen Hauptmann, Henning Dralle.   

Abstract

BACKGROUND: In papillary thyroid cancer, quantitative relationships may exist between central and lateral neck lymph node metastases, which may be of clinical usefulness.
METHODS: This comparative analysis of central and lateral neck lymph node metastases was undertaken in 88 patients with untreated papillary thyroid cancer who underwent compartment-oriented lymph node dissection in the central and ipsilateral lateral neck. In 32 of these patients, the contralateral lateral neck was dissected in addition.
RESULTS: Central lymph node metastases were categorized in increments of 0 (22 patients), 1-5 (29 patients), 6-10 (12 patients), and more than 10 positive nodes (25 patients). With more than 5 positive nodes, the rates and numbers of lateral lymph node metastases increased from between 45% and 69% to 100% and from a mean of between 2 and 3 to between 6 and 8 lymph node metastases (all P < .001) in the ipsilateral neck; and from between 0% and 33% to between 60% and 71% (P = .009) and from a mean of between 0 and 1 to between 3 and 7 lymph node metastases (P = .003) in the contralateral neck. Lateral lymph node metastases in the contralateral neck always coexisted with metastases in both the central and the opposite lateral neck. When only patients with positive lateral nodes were considered, the successive increase in the number of lateral lymph node metastases was still present. Altogether, the ipsilateral neck harbored more often lateral lymph node metastasis with more positive lateral nodes than the contralateral neck.
CONCLUSION: These histopathologic associations may provide a foundation for more evidence-based decisions regarding lymph node dissection of the lateral neck compartments in patients with node-positive papillary thyroid cancer.

Entities:  

Mesh:

Year:  2008        PMID: 19167972     DOI: 10.1016/j.surg.2008.09.003

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  26 in total

1.  In papillary thyroid cancer, preoperative central neck ultrasound detects only macroscopic surgical disease, but negative findings predict excellent long-term regional control and survival.

Authors:  Mauricio A Moreno; Beth S Edeiken-Monroe; Eric R Siegel; Steven I Sherman; Gary L Clayman
Journal:  Thyroid       Date:  2012-01-26       Impact factor: 6.568

2.  [Lateral skip metastases in papillary thyroid carcinoma].

Authors:  H Dralle
Journal:  Chirurg       Date:  2012-07       Impact factor: 0.955

Review 3.  The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy.

Authors:  Scott A Rivkees; Ernest L Mazzaferri; Frederik A Verburg; Christoph Reiners; Markus Luster; Christopher K Breuer; Catherine A Dinauer; Robert Udelsman
Journal:  Endocr Rev       Date:  2011-08-31       Impact factor: 19.871

4.  Contrast-enhanced ultrasound (CEUS) facilitated US in detecting lateral neck lymph node metastasis of thyroid cancer patients: diagnosis value and enhancement patterns of malignant lymph nodes.

Authors:  Dapeng Xiang; Yurong Hong; Bo Zhang; Pintong Huang; Guogang Li; Ping Wang; Zhiyu Li
Journal:  Eur Radiol       Date:  2014-07-09       Impact factor: 5.315

5.  Upregulation of the signal transducers and activators of transcription 3 (STAT3) pathway in lymphatic metastases of papillary thyroid cancer.

Authors:  Jingdong Zhang; Anthony Gill; Bryn Atmore; Amber Johns; Leigh Delbridge; Raymond Lai; Todd McMullen
Journal:  Int J Clin Exp Pathol       Date:  2011-04-28

6.  Does preoperative neutrophil lymphocyte ratio predict risk of recurrence and occult central nodal metastasis in papillary thyroid carcinoma?

Authors:  Brian Hung-Hin Lang; Cathy Po-Ching Ng; Kin Bun Au; Kai Pun Wong; Kandy K C Wong; Koon Yat Wan
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

Review 7.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

8.  [Surgery of thyroid carcinoma].

Authors:  H Dralle; K Lorenz; A Machens
Journal:  Chirurg       Date:  2009-11       Impact factor: 0.955

9.  Pattern of nodal involvement in papillary thyroid cancer: a challenge of quantitative analysis.

Authors:  Fausto Fama; Marco Cicciù; Giuseppe Lo Giudice; Alessandro Sindoni; Jessica Palella; Arnaud Piquard; Olivier Saint-Marc; Salvatore Benvenga; Ennio Bramanti; Gabriele Cervino; Maria Gioffre Florio
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

10.  ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells.

Authors:  Wangwang Qiu; Zhili Yang; Youben Fan; Qi Zheng
Journal:  Tumour Biol       Date:  2016-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.